These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10578478)

  • 1. N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells.
    Herbert BS; Sanders BG; Kline K
    Nutr Cancer; 1999; 34(2):121-32. PubMed ID: 10578478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
    Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
    Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells.
    Yu W; Heim K; Qian M; Simmons-Menchaca M; Sanders BG; Kline K
    Nutr Cancer; 1997; 27(3):267-78. PubMed ID: 9101557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
    Simeone AM; Colella S; Krahe R; Johnson MM; Mora E; Tari AM
    Carcinogenesis; 2006 Mar; 27(3):568-77. PubMed ID: 16199439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1.
    Yu W; Sanders BG; Kline K
    Nutr Cancer; 2002; 43(2):227-36. PubMed ID: 12588702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
    Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells.
    Charpentier A; Simmons-Menchaca M; Yu W; Zhao B; Qian M; Heim K; Sanders BG; Kline K
    Nutr Cancer; 1996; 26(2):237-50. PubMed ID: 8875561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
    Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
    Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
    Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
    Ohlmann CH; Jung C; Jaques G
    Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients.
    Torrisi R; Pensa F; Orengo MA; Catsafados E; Ponzani P; Boccardo F; Costa A; Decensi A
    Cancer Res; 1993 Oct; 53(20):4769-71. PubMed ID: 8402658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamide.
    Pellegrini R; Mariotti A; Tagliabue E; Bressan R; Bunone G; Coradini D; Della Valle G; Formelli F; Cleris L; Radice P
    Cell Growth Differ; 1995 Jul; 6(7):863-9. PubMed ID: 7547508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.
    Simeone AM; Deng CX; Kelloff GJ; Steele VE; Johnson MM; Tari AM
    Carcinogenesis; 2005 May; 26(5):1000-7. PubMed ID: 15695235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell death induced by N-(4-hydroxyphenyl)retinamide in human epidermal keratinocytes is modulated by TGF-beta and diminishes during the progression of squamous cell carcinoma.
    Davies M; Paterson IC; Ganapathy A; Prime SS
    Int J Cancer; 2006 Dec; 119(12):2803-11. PubMed ID: 17044020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K; Su J; Trovitch PB
    J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.
    Shan D; Gopal AK; Press OW
    Clin Cancer Res; 2001 Aug; 7(8):2490-5. PubMed ID: 11489831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective TGF-beta signaling sensitizes human cancer cells to rapamycin.
    Gadir N; Jackson DN; Lee E; Foster DA
    Oncogene; 2008 Feb; 27(8):1055-62. PubMed ID: 17700525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAG-1 promotes apoptosis induced by N-(4-hydroxyphenyl)retinamide in human cervical carcinoma cells.
    Yang X; Hao Y; Ding Z; Pater A
    Exp Cell Res; 2000 May; 256(2):491-9. PubMed ID: 10772821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.